Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes

Ebenezer David, Jonathan L. Kaufman, Christopher R. Flowers, Katherine Schafer-Hales, Claire Torre, Jing Chen, Adam I. Marcus, Shi Yong Sun, Lawrence H. Boise, Sagar Lonial

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

In this report, we investigated the mechanism responsible for synergistic induction of myeloma cell apoptosis induced by the combination of tipifarnib and bortezomib. Immunofluorescence studies revealed that bortezomib alone resulted in an accumulation of puncta of ubiquitinated proteins that was further enhanced by the addition of tipifarnib. These data suggest inhibition of the degradation of bortezomib-induced aggresomes; and consistent with this possibility, we also observed an increase in p62SQSTM1 in cells treated with the combination. However, autophagy in these cells appears to be normal as LC3BII is present, and autophagic flux appears to be unaffected as demonstrated by the addition of bafilomycin A1. Together, these data demonstrate that tipifarnib synergizes with bortezomib by inducing protein accumulation as a result of the uncoupling of the aggresome and autophagy pathways.

Original languageEnglish (US)
Pages (from-to)5285-5288
Number of pages4
JournalBlood
Volume116
Issue number24
DOIs
StatePublished - Dec 9 2010
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes'. Together they form a unique fingerprint.

Cite this